Nanoparticle-Based Therapeutics for Brain Injury

Vimala N. Bharadwaj, Duong T. Nguyen, Vikram Kodibagkar, Sarah Stabenfeldt

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Brain injuries affect a large patient population with major physical and emotional suffering for patients and their relatives; at a significant cost to the society. Effective diagnostic and therapeutic options available for brain injuries are limited by the complex brain injury pathology involving blood-brain barrier (BBB). Brain injuries, including ischemic stroke and brain trauma, initiate BBB opening for a short period of time, which is followed by a second reopening for an extended time. The leaky BBB and/or the alterations in the receptor expression on BBB may provide opportunities for therapeutic delivery via nanoparticles (NPs). The approaches for therapeutic interventions via NP delivery are aimed at salvaging the pericontusional/penumbra area for possible neuroprotection and neurovascular unit preservation. The focus of this progress report is to provide a survey of NP strategies employed in cerebral ischemia and brain trauma and finally provide insights for improved NP-based diagnostic/treatment approaches.

Original languageEnglish (US)
JournalAdvanced healthcare materials
DOIs
StateAccepted/In press - 2017

Fingerprint

Blood-Brain Barrier
Nanoparticles
Brain Injuries
Brain
Therapeutics
Brain Ischemia
Salvaging
Stroke
Pathology
Costs and Cost Analysis
Pain
Population
Traumatic Brain Injury
Costs

Keywords

  • Blood-brain barrier
  • Cerebral ischemia
  • Nanoparticles
  • Therapeutic nanoparticle delivery
  • Traumatic brain injury

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering
  • Pharmaceutical Science

Cite this

Nanoparticle-Based Therapeutics for Brain Injury. / Bharadwaj, Vimala N.; Nguyen, Duong T.; Kodibagkar, Vikram; Stabenfeldt, Sarah.

In: Advanced healthcare materials, 2017.

Research output: Contribution to journalArticle

@article{07cc4f55f441404abef9aa1413b8745b,
title = "Nanoparticle-Based Therapeutics for Brain Injury",
abstract = "Brain injuries affect a large patient population with major physical and emotional suffering for patients and their relatives; at a significant cost to the society. Effective diagnostic and therapeutic options available for brain injuries are limited by the complex brain injury pathology involving blood-brain barrier (BBB). Brain injuries, including ischemic stroke and brain trauma, initiate BBB opening for a short period of time, which is followed by a second reopening for an extended time. The leaky BBB and/or the alterations in the receptor expression on BBB may provide opportunities for therapeutic delivery via nanoparticles (NPs). The approaches for therapeutic interventions via NP delivery are aimed at salvaging the pericontusional/penumbra area for possible neuroprotection and neurovascular unit preservation. The focus of this progress report is to provide a survey of NP strategies employed in cerebral ischemia and brain trauma and finally provide insights for improved NP-based diagnostic/treatment approaches.",
keywords = "Blood-brain barrier, Cerebral ischemia, Nanoparticles, Therapeutic nanoparticle delivery, Traumatic brain injury",
author = "Bharadwaj, {Vimala N.} and Nguyen, {Duong T.} and Vikram Kodibagkar and Sarah Stabenfeldt",
year = "2017",
doi = "10.1002/adhm.201700668",
language = "English (US)",
journal = "Advanced healthcare materials",
issn = "2192-2640",
publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Nanoparticle-Based Therapeutics for Brain Injury

AU - Bharadwaj, Vimala N.

AU - Nguyen, Duong T.

AU - Kodibagkar, Vikram

AU - Stabenfeldt, Sarah

PY - 2017

Y1 - 2017

N2 - Brain injuries affect a large patient population with major physical and emotional suffering for patients and their relatives; at a significant cost to the society. Effective diagnostic and therapeutic options available for brain injuries are limited by the complex brain injury pathology involving blood-brain barrier (BBB). Brain injuries, including ischemic stroke and brain trauma, initiate BBB opening for a short period of time, which is followed by a second reopening for an extended time. The leaky BBB and/or the alterations in the receptor expression on BBB may provide opportunities for therapeutic delivery via nanoparticles (NPs). The approaches for therapeutic interventions via NP delivery are aimed at salvaging the pericontusional/penumbra area for possible neuroprotection and neurovascular unit preservation. The focus of this progress report is to provide a survey of NP strategies employed in cerebral ischemia and brain trauma and finally provide insights for improved NP-based diagnostic/treatment approaches.

AB - Brain injuries affect a large patient population with major physical and emotional suffering for patients and their relatives; at a significant cost to the society. Effective diagnostic and therapeutic options available for brain injuries are limited by the complex brain injury pathology involving blood-brain barrier (BBB). Brain injuries, including ischemic stroke and brain trauma, initiate BBB opening for a short period of time, which is followed by a second reopening for an extended time. The leaky BBB and/or the alterations in the receptor expression on BBB may provide opportunities for therapeutic delivery via nanoparticles (NPs). The approaches for therapeutic interventions via NP delivery are aimed at salvaging the pericontusional/penumbra area for possible neuroprotection and neurovascular unit preservation. The focus of this progress report is to provide a survey of NP strategies employed in cerebral ischemia and brain trauma and finally provide insights for improved NP-based diagnostic/treatment approaches.

KW - Blood-brain barrier

KW - Cerebral ischemia

KW - Nanoparticles

KW - Therapeutic nanoparticle delivery

KW - Traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=85031493054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031493054&partnerID=8YFLogxK

U2 - 10.1002/adhm.201700668

DO - 10.1002/adhm.201700668

M3 - Article

JO - Advanced healthcare materials

JF - Advanced healthcare materials

SN - 2192-2640

ER -